Overview

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blinded, vehicle-controlled, parallel-group study in Japanese subjects with acne vulgaris to demonstrate the efficacy of GI148512 (benzoyl peroxide [BPO] 3% gel) when applied once daily for 12 weeks. This study will also evaluate the safety of GI148512 when applied topically once daily for 12 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Benzoyl Peroxide